Global Asthma Device Market, By Type (Inhalers, Nebulizers, Dry Powder Inhalers, Metered-Dose Inhalers, Mesh Nebulizers), Indication (Asthma, COPD), Technology (Manually Operated, Digitally Operated), End-Users (Hospital, Retail Pharmacies, Online Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Asthma device market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 34,041.86 million and grow at a CAGR of 4.65% in the above-mentioned forecast period. Rising daily exposure to environmental pollution drives the asthma device market.
Asthma is defined as a chronic inflammatory lung disease which narrows the airways. Asthma causes recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Generally, the symptoms associated with asthma are short-lived and can be easily treated. Asthma inhalers are the type of medical devices which deliver medication into the body via the lungs, thereby, treating asthma and chronic obstructive pulmonary disease.
Increase in population susceptible to indoor air pollutants is the vital factor escalating the market growth, also rising portability of the drug delivery devices, rising population of active smokers, increasing government initiatives, rising demand for metered-dose inhalers, rising adoption of respiratory inhalers by hospitals and patients in European countries and rising cases of asthma and demand for better treatments in the Middle Eastern countries are the major factors among others driving the asthma device market. Moreover, rising patent expiration for blockbuster drugs, rising research and development activities and rising demand from the emerging economies will further create new opportunities for asthma device market in the forecasted period of 2021-2028.
However, rise in the price competition and deterioration of material quality, high cost of asthma treatment is a challenge for the patients and incompetent reimbursement support are the major factors among others which will obstruct the market growth, and will further challenge the growth of asthma device market in the forecast period mentioned above.
Asthma device market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on asthma device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asthma Device Market Scope and Market Size
Asthma device market is segmented on the basis of type, indication, technology and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, asthma device market is segmented into inhalers, nebulizers, dry powder inhalers, metered-dose inhalers and mesh nebulizers.
- Based on indication, the asthma device market is segmented into asthma and COPD.
- Based on technology, the asthma device market is segmented into manually operated and digitally operated.
- The asthma device market is also segmented on the basis of end-users into hospital, retail pharmacies and online pharmacies.
Asthma Device Market Country Level Analysis
Asthma device market is analysed and market size insights and trends are provided by country, type, indication, technology and end-users as referenced above.
The countries covered in the asthma device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific dominates the asthma device market due to rising presence of rapidly developing economies of China, India, and South Korea, high prevalence of asthma, as well as other respiratory diseases, rising portability of the drug delivery devices, rising population of active smokers, increasing government initiatives and rising demand for metered-dose inhalers in this region.
The country section of the asthma device market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Asthma device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for acetaminophen (Paracetamol) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the asthma device market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Asthma Device Market Share Analysis
Asthma device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to asthma device market.
The major players covered in the asthma device market report are GlaxoSmithKline plc, Koninklijke Philips N.V, AstraZeneca, Cipla Inc, Boehringer Ingelheim International GmbH, Beximco Pharmaceuticals Ltd, Merck Sharp & Dohme Corp (a subsidiary of Merck & Co., Inc.), CHIESI Farmaceutici S.p.A, Medisol Lifescience Pvt Ltd, Eklahare, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited., GENERAL ELECTRIC COMPANY, Getinge AB. and Inogen, Inc among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.